Status:
COMPLETED
Under and Over Rehabilitation Study
Lead Sponsor:
Queen Mary University of London
Collaborating Sponsors:
Roche Pharma AG
Barts & The London NHS Trust
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Multiple Sclerosis (MS) is a progressive neurological condition of the central nervous system for which there is no cure. Symptoms include motor and sensory dysfunction, bladder and bowel dysfunction ...
Detailed Description
MS is a chronic progressive disease of the central nervous system and is the leading cause of non-traumatic disability in young and middle aged adults. It commonly leads to cumulative, mixed disabilit...
Eligibility Criteria
Inclusion
- Being able to give online informed consent.
- Over the age of 18. There is no upper age limit.
- Have been diagnosed with Multiple Sclerosis more than 6 months ago and have an Expanded Disability Status Scale (EDSS) of over 6.0 as measured using the online webEDSS
- Understand and be able to communicate (read and write) in English
- Ability to use a computer and access the study resources on the internet
Exclusion
- Participants will be ineligible to participate if any inclusion criteria are not met.
- Patients unable to use their hands because of pain or anything that would interfere with the ability to complete the study interventions.
Key Trial Info
Start Date :
September 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2022
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT04490044
Start Date
September 1 2020
End Date
May 1 2022
Last Update
November 18 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Queen Mary University of London
London, United Kingdom, EC1M 6BQ